Ka Wang

Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Anthony W. Tolcher, Wells A. Messersmith, Stanislaw M. Mikulski et al. · Journal of Clinical Oncology · 2012 · 277 citations · Full text

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity

Xin‐Jie Chu, Wanda DePinto, David Bartkovitz et al. · Journal of Medicinal Chemistry · 2006 · 116 citations · Full text

Drug Target, Pharmacotherapy, Cell Cycle +17

Metabolic Profiles of Minimally Absorbed Orlistat in Obese/Overweight Volunteers

Jianguo Zhi, Angela T. Melia, Christoph Funk et al. · The Journal of Clinical Pharmacology · 1996 · 94 citations

Improved outcomes in patients with hepatitis C with difficult‐to‐treat characteristics

Michael Fried, Donald M. Jensen, M. Rodríguez‐Torres et al. · Hepatology · 2008 · 77 citations · Full text

Hierarchical Co–FeS₂/CoS₂ heterostructures as a superior bifunctional electrocatalyst

Ka Wang, Weilan Guo, Shancheng Yan et al. · RSC Advances · 2018 · 54 citations · Full text